Integrated Quantum Technologies Announces Refiling of MD&A

• Integrated Quantum Technologies refiled its Management's Discussion and Analysis (MD&A) for the period ended December 31, 2025.
• The refiling was triggered by a continuous disclosure review conducted by the BC Securities Commission.
• Revised disclosures clarify validation and testing activities related to AIQu™/Veil™ technologies and associated expenditures.
• No financial restatement is explicitly mentioned, but regulatory intervention indicates prior disclosures lacked sufficient clarity or compliance.

• Regulatory Friction: The requirement to refile MD&A due to a regulator review introduces governance risk and suggests potential misalignment between management reporting and securities law requirements.
• Sentiment Impact: While the refiling clarifies expenditures, the trigger (BCSC review) is inherently negative for investor confidence, particularly in a speculative growth stock context.
• Financial Implications: The news does not indicate a change to revenue or earnings projections, limiting immediate materiality on fundamentals but increasing compliance overhead and risk premium.
• Contextual Weight: Occurring after a price recovery from March lows ($0.50) to May levels ($0.70), this news acts as a dampener on the recent positive momentum driven by product validation and financing.

• Company: Integrated Quantum Technologies (formerly Integrated Cyber Solutions).
• Flagship Project: AIQu™ VEIL™ (Vector Encoded Information Layer).
• Technology: Proprietary Informationally Compressive Anonymization (ICA) designed to protect sensitive data in AI/ML pipelines without degrading performance.
• Commercial Status: Development completed; security validation passed (April 2026); currently seeking pilot implementations with enterprise customers.
• Market Positioning: Quantum-resilient, privacy-preserving infrastructure layer targeting regulated industries (finance, healthcare, government).